It has been quite a drudge since the last ELTP update in April on the release of Generic Hydroxyzine tablets. All that is left is erratic banter back and forth on the iHub boards (and a few other less significant boards) that demonstrates the anxious lot that awaits the fed's decision on the ELTP abuse deterrent pipeline.
